What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

Top urologists debunk prostate cancer myths, explain PSA testing, screening guidelines, risk factors, symptoms, and the ...

Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. | In its 2,000-patient Proteus ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...

Some men in England with the disease will now be offered an advanced form of treatment on the NHS.

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...